Evolutionary potential of HIV-1 capsid: mechanisms and consequences
HIV-1衣壳的进化潜力:机制和后果
基本信息
- 批准号:10762605
- 负责人:
- 金额:$ 53.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAntiviral AgentsBindingBiological AssayCD4 Positive T LymphocytesCapsidCellsChargeClinicClinicalCoculture TechniquesConeConsequences of HIVDNADrug DesignDrug InteractionsDrug resistanceEquine Infectious Anemia VirusEvolutionFutureGeneticHIV-1ImmuneInnate Immune ResponseIntegration Host FactorsKineticsKnowledgeLaboratoriesLentivirusMacrophageMediatingMolecularMutationMutation AnalysisNuclearNucleic AcidsPathway interactionsPharmaceutical PreparationsPhasePhenotypePlayProteinsResistanceResistance profileResolutionRestRoleShapesStructureSystemTechniquesTherapeuticTherapeutic InterventionVariantViralViral PhysiologyVirus DiseasesVirus LatencyVirus Replicationcell typecombinatorialdesigndrug developmentdrug resistance developmentexperimental studyfitnessgenetic approachhigh dimensionalityimprovedinhibitorinnate immune sensinginsightintegration sitemutation screeningnovelrecruitresponsesensortargeted treatmenttransmission processviral DNA
项目摘要
PROJECT SUMMARY
The viral capsid, a cone-shaped protein shell, plays multiple roles during HIV-1 replication and has emerged
as a promising antiviral target. It has been widely accepted that structural and functional constraints limit the
mutational tolerance of the capsid. However, there is growing appreciation that HIV-1 accommodates
phenotypic variability in nearly every capsid-mediated function without compromising viral replicative fitness.
These observations raise the possibility that the capability of HIV-1 capsid to adapt is likely underestimated
and substantial. The evolutionary potential of HIV-1 capsid has direct implications for drug resistance and
serves as the molecular basis for host factor utilization and evasion. In this application, building upon our
previous and preliminary studies, we propose to study the mechanisms and consequences of HIV-1 capsid
variability using a multi-pronged strategy with special focus on the use of large-scale genetic approaches. In
Aim 1, high-throughput mutational analysis of HIV-1 capsid will be conducted to generate comprehensive
resistance profiles of various capsid inhibitors. We will also explore how combinatorial use of different types
of capsid inhibitors can improve antiviral activity through synergistic interactions and/or by restricting
resistance pathways. In Aim 2, to elucidate how HIV-1 exploits multiple host factors via highly charged pores
at the center of each CA multimer, we will study the requirement for these cellular factors in capsid stability
and other post-entry steps among diverse lentiviruses. Additionally, deep mutational scanning and detailed
phenotyping will be applied to the central pore of HIV-1 capsid. In Aim 3, leveraging the availability of HIV-1
variants with varying uncoating kinetics, we will study the role of the capsid in shielding viral DNA from innate
sensors in the context of cell-to-cell transmission of HIV-1. Second, to determine how the impacts of the
capsid on viral DNA sensing can define the fate of viral infection, we will develop novel experimental assays
that enable quantification of viral latency and competitions in a co-culture system. These studies will increase
our understanding of the molecular basis for capsid-mediated functions. New findings will provide valuable
insights into the evolutionary potential of HIV-1 capsid and may be harnessed to aid in the discovery and
design of novel capsid targeting antivirals.
项目总结
病毒衣壳是一种锥形的蛋白外壳,在HIV-1复制过程中扮演着多种角色,并已出现
作为一个很有前途的抗病毒靶点。人们普遍认为,结构和功能的限制限制了
衣壳的突变耐受性。然而,人们越来越认识到,艾滋病毒-1适应了
在不影响病毒复制适合性的情况下,几乎每个衣壳介导的功能都具有表型可变性。
这些观察结果表明,HIV-1衣壳的适应能力可能被低估了。
也很充实。HIV-1衣壳的进化潜力与耐药性和
作为寄主因子利用和逃避的分子基础。在此应用程序中,基于我们的
在之前和初步的研究中,我们建议研究HIV-1衣壳的机制和后果
采用多管齐下的战略,特别注重使用大规模遗传方法,以提高可变性。在……里面
目标1,将对HIV-1衣壳进行高通量突变分析,以产生全面的
不同衣壳蛋白抑制剂的耐药谱。我们还将探索不同类型的组合用法如何
衣壳蛋白抑制剂可以通过协同作用和/或通过限制
耐药途径。在目标2中,阐明HIV-1如何通过高度带电的毛孔利用多种宿主因素
在每个CA多聚体的中心,我们将研究这些细胞因子对衣壳稳定性的要求
以及不同慢病毒之间的其他进入后步骤。此外,深度突变扫描和详细的
将对HIV-1衣壳的中央毛孔进行表型鉴定。在目标3中,利用艾滋病毒-1的可获得性
变异体具有不同的脱壳动力学,我们将研究衣壳在保护病毒DNA免受天然感染方面的作用
在艾滋病毒-1细胞间传播的背景下的传感器。第二,确定经济衰退的影响
病毒DNA上的衣壳可以决定病毒感染的命运,我们将开发新的实验检测方法
这使得在共培养系统中能够量化病毒潜伏期和竞争。这些研究将会增加
我们对衣壳介导功能的分子基础的理解。新的发现将提供有价值的
对HIV-1衣壳进化潜力的洞察,并可能被利用来帮助发现和
新型靶向抗病毒药物衣壳的设计。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.
- DOI:10.1186/s12977-021-00577-x
- 发表时间:2021-10-26
- 期刊:
- 影响因子:3.3
- 作者:Saito A;Yamashita M
- 通讯作者:Yamashita M
Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2.
- DOI:10.7554/elife.35738
- 发表时间:2018-08-07
- 期刊:
- 影响因子:7.7
- 作者:Kane M;Rebensburg SV;Takata MA;Zang TM;Yamashita M;Kvaratskhelia M;Bieniasz PD
- 通讯作者:Bieniasz PD
Toll-Like Receptor (TLR) Signaling Enables Cyclic GMP-AMP Synthase (cGAS) Sensing of HIV-1 Infection in Macrophages.
- DOI:10.1128/mbio.02817-21
- 发表时间:2021-12-21
- 期刊:
- 影响因子:6.4
- 作者:Siddiqui MA;Yamashita M
- 通讯作者:Yamashita M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Masahiro Yamashita其他文献
Highly selective H2 or O2 sorption over N2 in metal-organic frame-work with dynamic aperture
在具有动态孔径的金属有机框架中对 N2 进行高选择性 H2 或 O2 吸附
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
Shinya Takaishi;Bin Wu;Shin-ichiro Noro;Masahiro Yamashita - 通讯作者:
Masahiro Yamashita
シリル-NHCキレート配位子を持つイリジウム錯体の合成,構造および反応性
含硅烷基 NHC 螯合配体的铱配合物的合成、结构和反应活性
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Shinya Takaishi;Bin Wu;Shin-ichiro Noro;Masahiro Yamashita;桜庭 幹太,小室 貴士,飛田 博実 - 通讯作者:
桜庭 幹太,小室 貴士,飛田 博実
Masahiro Yamashita的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Masahiro Yamashita', 18)}}的其他基金
Single-cell analysis of HIV-1 production and transmission
HIV-1 产生和传播的单细胞分析
- 批准号:
10086846 - 财政年份:2019
- 资助金额:
$ 53.84万 - 项目类别:
Single-cell analysis of HIV-1 production and transmission
HIV-1 产生和传播的单细胞分析
- 批准号:
9906849 - 财政年份:2019
- 资助金额:
$ 53.84万 - 项目类别:
Single-cell analysis of HIV-1 production and transmission
HIV-1 产生和传播的单细胞分析
- 批准号:
10132234 - 财政年份:2019
- 资助金额:
$ 53.84万 - 项目类别:
Single-cell analysis of HIV-1 production and transmission
HIV-1 产生和传播的单细胞分析
- 批准号:
10589935 - 财政年份:2019
- 资助金额:
$ 53.84万 - 项目类别:
Single-cell analysis of HIV-1 production and transmission
HIV-1 产生和传播的单细胞分析
- 批准号:
10375452 - 财政年份:2019
- 资助金额:
$ 53.84万 - 项目类别:
Mechanism and role of nuclear entry in HIV-1 replication
HIV-1复制中核进入的机制和作用
- 批准号:
8639465 - 财政年份:2012
- 资助金额:
$ 53.84万 - 项目类别:
Diverse Functions of HIV-1 Capsid During Postentry Events
HIV-1衣壳在进入后事件期间的多种功能
- 批准号:
10081224 - 财政年份:2012
- 资助金额:
$ 53.84万 - 项目类别:
Mechanism and role of nuclear entry in HIV-1 replication
HIV-1复制中核进入的机制和作用
- 批准号:
8449072 - 财政年份:2012
- 资助金额:
$ 53.84万 - 项目类别:
Diverse Functions of HIV-1 Capsid During Postentry Events
HIV-1衣壳在进入后事件期间的多种功能
- 批准号:
9979730 - 财政年份:2012
- 资助金额:
$ 53.84万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 53.84万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 53.84万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 53.84万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 53.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 53.84万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 53.84万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 53.84万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 53.84万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 53.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 53.84万 - 项目类别: